13 November 2017
Enhanced understanding of the microbiome is helping medicine via The Economist
Enterome, Eligo Bioscience and Seventure Partners inside !
All
10 November 2017
Seventure Partners announces the trade sale of its portfolio company Cambrooke Therapeutics, Inc. to Ajinomoto Co. Inc
Seventure Partners, one of Europe’s leaders in financing innovation and a world-leader in the venture investment in the microbiome sector, today announces the trade sale of...
30 October 2017
Enterome’s EB8018, a first-in-class drug candidate targeting Crohn’s disease, successfully completes Phase I study in healthy volunteers
ENTEROME SA, a pioneer of innovative therapies for microbiome-related diseases, is pleased to announce the successful completion of the first Phase 1 clinical study with its...
28 September 2017
LNC THERAPEUTICS raises € 6,5 million and reinforces its R&D in the microbiota field
Cardiometabolic research specialist announces Sandrine Claus appointment as Chief Scientific Officer to lead its microbiota-oriented ambitious strategy.
26 September 2017
Eligo Bioscience Secures $20 Million Series A from Khosla Ventures and Seventure to Bring Precision Medicine to the Microbiome
Eligo Bioscience, the French microbiome company developing drugs to prevent and treat bacteria-associated diseases, has secured a $20 million Series A round of financing from...
18 September 2017
Health for Life Capital™ participates in $35m Series B of Foodscience MycoTechnology Inc and confirms its visionary strategy
Health for Life Capital is the only non-American investor alongside prestigious strategic and financial investors.
20 July 2017
MaaT Pharma completes patient recruitment of its Odyssée clinical trial
Within thirty months of its creation, MaaT Pharma, a European MicrobioTech1 specialized in the development of innovative treatments based on intestinal microbiota in...
20 July 2017
Enterome and Nestlé Health Sciences launch new diagnostics company
ENTEROME SA, a pioneer of innovative therapies for microbiome-related diseases, and Nestlé Health Science, announce the joint creation of Microbiome Diagnostics Partners...
6 July 2017
Seventure’s Health for Life Capital™ participates in $26.1m financing of Europe’s largest digital health provider, Push Doctor
Europe’s largest digital health provider, Push Doctor, announces that it has raised $26.1M in a Series B funding round led by Accelerated Digital Ventures (“ADV” – the...
5 July 2017
Health for Life Capital™ Participates in $13.2m Financing of Japanese microbiome leader Anaeropharma Science Innovative, a biotech company that uses live bacteria to fight cancer
Paris, France – July 5, 2017 - Seventure Partners, one of Europe’s leaders in financing innovation, and a world-leader in the venture investment in the microbiome sector,...